← All stocks

ORAMED PHARMACEUTICALS INC.

ORMP Net selling
CIK 0001176309 #3940 in the set updated 17 Sep 2026
Bought (120 mo)
$1.80M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$7.44M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$7.44M
12 of 12 sales
Net
−$5.65M
−$5.65M against sales at will

By person

18 insiders · 42 transactions
25.8×

Nadav Kidron holds 25.8 times base salary in stock. $16.00M of shares against $619.53K in salary for 2025.

Salary from the company's own proxy. The shares are what Nadav Kidron last reported holding, valued at $4.51, the price Common Stock was last bought or sold at on the open market here, on 1 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
KIDRON NADAV
President and CEO
$254.74K (3)
$4.42M (2)
−$4.17M
3,548,243
8.53%
$16.00M
+253.8%
Kidron Miriam
Chief Scientific Officer
$1.30M (3)
−$1.30M
1,133,138
2.72%
$5.11M
+395.7%
Li Xiaopeng
Director
$1.10M (2)
+$1.10M
206,350
0.4961%
$930.33K
Hexter Joshua
COO & CBO
$611.43K (1)
−$611.43K
1,073,384
2.58%
$4.84M
RAKIN KEVIN
Director
$536.93K (2)
−$536.93K
46,661
0.1122%
$210.37K
Gabay Avraham
Chief Financial Officer
$330.74K (1)
−$330.74K
671,785
1.61%
$3.03M
Sank Leonard
Director
$272.96K (7)
+$272.96K
351,545
0.8451%
$1.58M
−37.9%
Rabinowitz Michael
Chief Commercial Officer
$167.20K (2)
−$167.20K
126,143
0.3032%
$568.72K
+15.2%
Rozov Yadin
Director
$141.57K (2)
+$141.57K
155,320
0.3734%
$700.26K
Mayer Arie
Director
$19.52K (2)
$76.80K (1)
−$57.28K
168,009
0.4039%
$757.47K
+5,500%
Friedman Aviad
Director
$12.37K (2)
+$12.37K
12,191
0.0293%
$54.96K
+25.8%
Slager David Mark
Director
1,316,328
3.16%
$5.93M
+10.9%
Silberman David
Chief Financial Officer
366,500
0.8811%
$1.65M
Derovan Netanel
Chief Legal Officer
149,500
0.3594%
$674.02K
Shapiro Benjamin
Director
123,220
0.2962%
$555.54K
Aghion Daniel
Director
113,441
0.2727%
$511.45K
Rabinowitz Michael
Chief Commercial Officer
109,468
0.2632%
$493.54K
Reznick Yehuda
Director
105,180
0.2529%
$474.20K
Insider
Date
Role
Action
Shares
Price
Amount
Mayer Arie
4 Apr 2023
Director
Buy
3,800
$2.21
$8.40K
Mayer Arie
3 Apr 2023
Director
Buy
5,009
$2.22
$11.12K
KIDRON NADAV
16 Mar 2023
President and CEO
Buy indirect
26,000
$2.04
$53.01K
Rozov Yadin
14 Mar 2023
Director
Buy
50,000
$2.05
$102.45K
KIDRON NADAV
14 Mar 2023
President and CEO
Buy indirect
100,000
$2.01
$201.00K
Rozov Yadin
13 Mar 2023
Director
Buy
20,000
$1.96
$39.12K
Sank Leonard
9 Sep 2019
Director
Buy
10,000
$2.95
$29.50K
Sank Leonard
9 Sep 2019
Director
Buy
15,000
$2.90
$43.50K
Sank Leonard
18 Jul 2019
Director
Buy
4,497
$3.86
$17.34K
Sank Leonard
17 Jul 2019
Director
Buy
10,020
$3.74
$37.50K
Sank Leonard
17 Jul 2019
Director
Buy
20,000
$3.58
$71.56K
Sank Leonard
16 Jul 2019
Director
Buy
20,000
$3.47
$69.32K
Sank Leonard
11 Jul 2019
Director
Buy
1,320
$3.22
$4.25K
Friedman Aviad
9 Aug 2018
Director
Buy indirect
2,000
$4.98
$9.96K
Friedman Aviad
9 Aug 2018
Director
Buy indirect
500
$4.82
$2.41K
KIDRON NADAV
11 Jul 2018
President and CEO
Buy
122
$5.92
$722.18
Li Xiaopeng
2 Aug 2017
Director
Buy
89,636
$8.50
$761.91K
Li Xiaopeng
19 Apr 2017
Director
Buy
52,814
$6.33
$334.31K

What was left out

Form 4 filings counted 171
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 12
Transactions with no price 0
Shares from compensation/vesting 9,641,870
Sales filed before the plan box existed 10
History held since 7 Nov 2016